Advertisement Banner
  • Home
  • News
  • Medicine
  • Health Tech
  • Health Living
  • Contact
No Result
View All Result
  • Home
  • News
  • Medicine
  • Health Tech
  • Health Living
  • Contact
No Result
View All Result
HealthNews
No Result
View All Result
Home Health Living

Owlet cuts expenses as baby tech company ‘rebuilds’

March 17, 2023
in Health Living

Source Link: https://www.mobihealthnews.com/news/owlet-cuts-expenses-baby-tech-company-rebuilds



Baby tech company Owlet cut expenses in the second half of the year as it made new submissions to the FDA, pitching the moves as steps toward profitability.

The company reported $69.2 million in revenue in 2022 compared to $75.8 million in 2021. Operating expenses were $107.9 million last year, compared to $90.9 million in 2021. 

But Owlet said the increase was largely due to the launch of its Dream Sock sleep monitoring wearables early in the year. In the second half of 2022, the company cut marketing spend, laid off employees and reduced other expenses that it said will position it for profitability in 2023.

Owlet posted a net loss of $79.3 million last year compared with $71.7 million in 2021. 

In the fourth quarter, the baby tech company reported about $12 million in revenue and a net loss of $19.5 million. Operating expenses were $24.1 million in the fourth quarter last year compared to $27.3 million in the prior-year period. 

“I recognize that our confidence in our business conflicts with our reported financial results in 2022 due to the efforts required to rebuild our business,” CEO and cofounder Kurt Workman said during an earnings call. “[…] Throughout 2022, we made tremendous progress positioning Owlet for sustainable, profitable growth in 2023 and years into the future. We rebuilt our brand health, rebased our operating expenses, focused on rebuilding channel health and made milestone progress towards regulatory approval for both our medical device and de novo product applications.”

Workman said the Owlet will continue to cut costs in the first half of the year. The company now employs less than 100 people compared with 227 last year.

He added that Owlet filed for an FDA 510(k) for an infant prescription monitoring device in October. The device, which the company internally calls BabySat, aims to alert parents when their baby’s heart rate or blood oxygen saturation falls out of a prescribed range.

In December, the company submitted to the FDA for an over-the-counter product that provides heart rate and oxygen notifications in addition to the Dream Sock’s sleep monitoring tools.

“The most critical accomplishments towards Owlet’s digital healthcare future is the work we’ve done to pursue regulatory clearances for our products in 2022,” Workman said. “As stated in prior calls, we believe in making the highest quality care available to every baby by democratizing access to technology and information that has previously been limited to clinical settings.”

THE LARGER TREND

Owlet went public in 2021 after merging with a special purpose acquisition company. Later that year, the company pulled its Smart Sock wearables from the market after receiving a warning letter from the FDA. The agency said Owlet was marketing the products as “diagnosis” tools, which would require 510(k) clearance.

Last month, Owlet announced it had raised $30 million in private placement financing. 



Source link

Advertisement Banner
Previous Post

Russian hacker group Phoenix targets health ministry systems, Health News, ET HealthWorld

Next Post

Quercetin — A Far Better Flu Remedy Than Tamiflu

Next Post

Quercetin — A Far Better Flu Remedy Than Tamiflu

Discussion about this post

Recommended

Metaverse evolution can demystify myths of disease progression & clinical trials for drugs, Health News, ET HealthWorld

9 months ago

Chatbot-delivered intervention increases seasonal influenza vaccine uptake in older adults

3 months ago

Don't Miss

Why Does National Security Depend on Forever Chemicals?

December 6, 2023

Endoluminal robotics company EndoQuest scores $42M

December 6, 2023

Gen AI speeds up workflows, drug development, Health News, ET HealthWorld

December 6, 2023

Struggling With Stress? Consider Avoiding Fatty Food For Better Recovery

December 6, 2023

© Pharma News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • News
  • Medicine
  • Health Tech
  • Health Tech
  • Health Living
  • Contact
  • Privacy Policy

Newsletter Sign Up.

No Result
View All Result
  • Home
  • News
  • Medicine
  • Health Tech
  • Health Living
  • Contact

© 2022 Pharma News Hubb All rights reserved.